<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251201068171N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-30</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of topical melatonin combined with xenogeneic bone graft powder on bone formation and the width of keratinized gingiva in the extraction site.</public_title>
      <acronym></acronym>
      <scientific_title>The effect of using melatonin hormone locally along with xenograft on bone regeneration and improving the quality of soft tissue in the extracted tooth area</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87850</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment, Randomization description: Randomization method:
In this split-mouth study, each patient served as their own control. Sites within the mouth (e.g., right or left side) were randomly assigned to the intervention or control. Random allocation was performed using a random number table to minimize bias, Blinding description: 1 Patient Blinding
	•	Patients were unaware of which side of the mouth was assigned to the intervention group (melatonin + xenograft) and which side was assigned to the control group (xenograft only)

2 Surgeon and Evaluator Blinding
	•	The surgeon was unaware of the allocation during the intervention and tissue sampling
	•	Clinical and histological evaluators were also blinded to the allocation of each site

3 Allocation Control
	•	Group allocation was performed by an independent person and the information was kept in sealed envelopes
	•	The envelopes were opened only at the time of the intervention by the responsible operator.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Dental socket preservation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, following tooth extraction, the extraction socket is filled with xenograft bone powder combined with melatonin.This study is designed as a split-mouth trial, in which one side of each patient’s mouth is randomly assigned to receive the intervention (xenograft with melatonin), while the contralateral side serves as the control group and receives xenograft bone powder alone without melatonin. Intervention 2: Control group: In the control group, following tooth extraction, the extraction socket is filled with xenograft bone powder without melatonin.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data will be published as part of a peer-reviewed article

When:
Access to the data will be available after final publication of the article.

To whom:
The data may be accessible by the general public

Conditions:
provided that proper citation to the published article is made.

Where to obtain:
Requests for access to the data should be directed to the corresponding author via email.

How to obtain:
Correspondence via email with the corresponding author.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahdi Nozhati Maleki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan Boys' Dormitory, Sari Zamin, First Uphill of Mirdamad, University Square, Tabriz, East Azerbaijan</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5165995131   				  	</zip>
        <telephone>+98 41 3784 2502</telephone>
        <email>Mahdinozhati2002@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farzain Ahmadpour pournak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan Boys' Dormitory, Sari Zamin, First Uphill of Mirdamad, University Square, Tabriz, East Azerbaijan</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5165995131</zip>
        <telephone>+98 41 3784 2502</telephone>
        <email>phoenixinfire@ymail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with non-restorable teeth who are candidates for implant treatment</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, following tooth extraction, the extraction socket is filled with xenograft bone powder combined with melatonin.This study is designed as a split-mouth trial, in which one side of each patient’s mouth is randomly assigned to receive the intervention (xenograft with melatonin), while the contralateral side serves as the control group and receives xenograft bone powder alone without melatonin.</i_keyword>
      <i_keyword>Control group: In the control group, following tooth extraction, the extraction socket is filled with xenograft bone powder without melatonin.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Primary Outcome Variable Description:The primary outcome variable is the amount of newly formed bone in the dental socket after using melatonin combined with xenograft compared to xenograft alone. Timepoint: Time Points of Measurement:	1.	Baseline (before tooth extraction / intervention): Measurement of attached gingiva thickness as a reference for soft tissue evaluation	2.	Immediately after material placement in the dental socket: Initial clinical observations recorded	3.	Week 1 and Week 2 post-surgery: Clinical follow-up including suture closure, swelling, infection, and unpleasant odor	4.	Two months post-surgery:	•	Bone sampling from both intervention and control sites before implant placement	•	Radiographic assessment to evaluate bone status and structural changes. Method of measurement: The bone formation is measured using histological analysis (histomorphometry) or image analysis software (Image-Pro Plus)	•	Results are reported as the percentage of new bone relative to the total tissue section area.</prim_outcome>
      <prim_outcome>The secondary outcome variable is attached gingiva thickness around the dental socket, reflecting soft tissue changes after using melatonin combined with xenograft compared to xenograft alone. Timepoint: 1.	Baseline (before tooth extraction / intervention): Measurement of attached gingiva thickness using a periodontal probe	2.	Immediately after material placement in the dental socket: Recording initial clinical observations of the gingiva	3.	Week 1 and Week 2 post-surgery: Clinical assessment of the gingiva, including swelling, inflammation, and soft tissue healing	4.	Two months post-surgery: Re-measurement of attached gingiva thickness to evaluate soft tissue changes. Method of measurement: Measurements are performed using a periodontal probe and recorded at predefined time points.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-11-22</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Golestan Boys' Dormitory, Sari Zamin, First Uphill of Mirdamad, University Square, Tabriz, East Azerbaijan Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
